Clopidogrel Resistance Among Ischemic Stroke Patients and Its Risk Factors in Indonesia

OBJECTIVE. Clopidogrel is a common antiplatelet used as secondary prevention of ischemic stroke, known to have better efficacy than aspirin, with a equivalent safety profile. However, clopidogrel resistance is not uncommon but has not been widely studied in Asia. This study will further assess clopi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidayat, Rakhmad, Nabilah, Rizqi Amanda, Rasyid, Al, Harris, Salim, Harahap, Alida R., Herqutanto, Louisa, Melva, Listyaningsih, Erlin, Rambe, Aldy Safruddin, Loho, Tonny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Sciences and Arts of Bosnia and Herzegovina 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982849/
https://www.ncbi.nlm.nih.gov/pubmed/35695400
http://dx.doi.org/10.5644/ama2006-124.367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982849/
https://www.ncbi.nlm.nih.gov/pubmed/35695400
http://dx.doi.org/10.5644/ama2006-124.367

Ejemplares similares